While earlier reports suggest that IL-6 can independently induce EMT-like features in multiple cancer types (60), in our study, at the stipulated dose, simultaneous addition of IL-6 with TGF-β did not enhance a robust EMT feature, as evident from the expression of EMT-associated markers (Figure 5F). Here, TGFB1 is linked to cancer.